<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02701855</url>
  </required_header>
  <id_info>
    <org_study_id>14DRM_EYEBRAIN</org_study_id>
    <nct_id>NCT02701855</nct_id>
  </id_info>
  <brief_title>Retina Microvascular Remodeling and Cognitive Function In Hypertension</brief_title>
  <acronym>EYEBRAIN</acronym>
  <official_title>Retina Microvascular Remodeling and Cognitive Function In Hypertension : Eyebrain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Cardiometabolism and Nutrition, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondation de Recherche sur l'Hypertension Artérielle</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institute of Cardiometabolism and Nutrition, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine the relationships between retina micro-vascular remodeling and
      cognitive function in hypertensive patients.

      The study plans to enrol 160 patients (100 patients with mild cognitive impairment -MCI- and
      60 without MCI).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our project stands on physiopathological and cognitive angles, and is mainly based on the
      major role of large and small arteries elasticity on cognitive aging. It will benefit from
      the recent innovative accurate and non invasive techniques such as MRI for central large
      arteries and adaptative optics for retina arterioles imaging.

      Study population is the following:

        -  60 patients with hypertension and no MCI,

        -  50 patients with hypertension and stable MCI, without dementia

        -  50 patients with hypertension and progressive MCI, without dementia

      Every patients will perform a medical interview and examination, an MRI (brain + aorta),
      adaptative optics imaging, a cognitive tests and a blood test.

      Primary outcome is to determine the relationships between retina micro-vascular remodeling
      and cognitive function in this population.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Relationships between retina micro-vascular remodeling and cognitive function in hypertensive patients.</measure>
    <time_frame>September 2017</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>• Associations between cognitive function and proximal aortic stiffness indices estimated from MRI images.</measure>
    <time_frame>September 2017</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Associations between retina arteriolar remodelling and cerebrovascular lesions (infarcts, lacuna, and white matter lesions) quantified from MRI images.</measure>
    <time_frame>September 2017</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Associations between retina arteriolar remodelling and neurodegenerative lesions (hippocampus atrophy) quantified from MRI images.</measure>
    <time_frame>September 2017</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Associations between proximal aortic stiffness and cerebrovascular lesions (infarcts, lacuna, and white matter lesions) quantified from MRI images.</measure>
    <time_frame>September 2017</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Associations between proximal aortic stiffness and neurodegenerative lesions (hippocampus atrophy) quantified from MRI images.</measure>
    <time_frame>September 2017</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Associations between retina arteriolar remodelling and proximal aortic stiffness indices.</measure>
    <time_frame>September 2017</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Hypertension</condition>
  <condition>Mild Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>Hypertension and progressive MCI</arm_group_label>
    <description>50 subjects will perform brain and aorta RMI, blood test, cognitive tests and adaptative optics.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypertension and stable MCI</arm_group_label>
    <description>50 subjects will perform brain and aorta RMI, blood test, cognitive tests and adaptative optics.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypertension, without MCI</arm_group_label>
    <description>60 subjects will perform brain and aorta RMI, blood test, cognitive tests and adaptative optics.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive tests</intervention_name>
    <description>Cognitive tests include:
The MMSE (Mini Mental State Examination)
Free and Cued Selective Recall Reminding Test (FCSRT).
Executive functions (fluencies, TMT A and B, span).
Tests of verbal fluency (literal and category)
Digit symbol substitution test or Wechsler adult intelligence scale (W.A.I.S)
The Clinical Dementia Rating Scale
The IADL scale evaluates autonomy.
Geriatric Depression screening Scale (GDS)</description>
    <arm_group_label>Hypertension and progressive MCI</arm_group_label>
    <arm_group_label>Hypertension and stable MCI</arm_group_label>
    <arm_group_label>Hypertension, without MCI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood test</intervention_name>
    <description>A blood test will be performed in order to collect following parameters: Urea, BUN, Creatinine, Potassium, Sodium, hematocrit, hsCRP, NFS, Pq, LDL-C, HDL-C, Triglycerides, Lp(a), Lp-PLA2 as well as fasting glucose, HbA1C and microalbuminuria</description>
    <arm_group_label>Hypertension and progressive MCI</arm_group_label>
    <arm_group_label>Hypertension and stable MCI</arm_group_label>
    <arm_group_label>Hypertension, without MCI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Brain and aorta RMI</intervention_name>
    <description>A magnetic resonance imaging exam will be performed at the Neuroimaging Research Center of the Pitié-Salpêtrière Hospital. This exam will be optimized to fit in 30 minutes. Indeed brain 3D T1 and T2 FLAIR imaging lasts 15 minutes while cine and velocity encoded imaging of the aorta lasts 15 minutes.</description>
    <arm_group_label>Hypertension and progressive MCI</arm_group_label>
    <arm_group_label>Hypertension and stable MCI</arm_group_label>
    <arm_group_label>Hypertension, without MCI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Adaptative optics</intervention_name>
    <description>The retina adaptative optic imaging will be performed at the &quot;Unité de prevention des maladies cardiovasculaires&quot; Pitié Salpetrière Hospital. This exam lasts 10 minutes including patient positioning and imaging.</description>
    <arm_group_label>Hypertension and progressive MCI</arm_group_label>
    <arm_group_label>Hypertension and stable MCI</arm_group_label>
    <arm_group_label>Hypertension, without MCI</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients' recruitment will be carried out in two centers to ensure inclusion of both
        patients: 1) with hypertension and without cognitive impairment, 2) with hypertension and
        with mild cognitive impairment (without dementia) including patients with stable MCI and
        converters.

        Population size: 160 patients:

          -  60 patients with hypertension and no MCI,

          -  50 patients with hypertension and stable MCI, without dementia

          -  50 patients with hypertension and progressive MCI, without dementia
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Aged 65 or more

          2. hypertension (BP ≥140/90 mmHg and/or antihypertensive treatment)

          3. Signed informed consent by the patient

          4. Sufficient mastery of the French language to perform neuropsychological tests

        Exclusion Criteria:

          1. Impossibility to visualize the retinal : severe cataract

          2. Dementia (defined by MMSE&lt;20)

          3. Clinical stroke

          4. Severe or resistant Hypertension

          5. Hypertension treated with more than 3 different pharmacological classes

          6. any other disease that may interfere with the assessment of cognitive disorders
             (epilepsy, Parkinson's disease, major depression, schizophrenia, manic-depressive)

          7. Enrolment in a therapeutic trial that could interfere with the main objective

          8. Less than 4 years of formal education

          9. Illiterate, unable to read, write or count

         10. major physical problems that may interfere with the tests (sight, hearing, ...)

         11. Short term life threatening disease

         12. Non-affiliation to a healthcare system

         13. Consent refusal

         14. Contraindication to MRI including claustrophobia, metallic devices, pacemaker,
             mechanical valve implanted before 1985, and nursing, as well as technical
             contra-indication: patient diameter &gt; 70 cm or/and weight &gt; 250 kg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>David Rosenbaum, Dr</last_name>
    <phone>01 42 17 57 74</phone>
    <phone_ext>+33</phone_ext>
    <email>david.rosenbaum@psl.aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Unité de prévention des maladies cardiovasculaires Pôle Cardiologie/Métabolisme Hôpital Pitié-Salpétriêre, APHP, 83 bd de l'hôpital,</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Rosenbaum, Dr</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M; Alzheimer's Disease International. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005 Dec 17;366(9503):2112-7.</citation>
    <PMID>16360788</PMID>
  </reference>
  <reference>
    <citation>Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology. 2005 Aug 23;65(4):545-51.</citation>
    <PMID>16116114</PMID>
  </reference>
  <reference>
    <citation>Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, Havlik RJ. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2000 Jan-Feb;21(1):49-55.</citation>
    <PMID>10794848</PMID>
  </reference>
  <reference>
    <citation>Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005 Aug;4(8):487-99. Review.</citation>
    <PMID>16033691</PMID>
  </reference>
  <reference>
    <citation>Perlmutter LS, Barrón E, Saperia D, Chui HC. Association between vascular basement membrane components and the lesions of Alzheimer's disease. J Neurosci Res. 1991 Dec;30(4):673-81.</citation>
    <PMID>1787541</PMID>
  </reference>
  <reference>
    <citation>Hardy JA, Mann DM, Wester P, Winblad B. An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiol Aging. 1986 Nov-Dec;7(6):489-502. Review.</citation>
    <PMID>2882432</PMID>
  </reference>
  <reference>
    <citation>Vagnucci AH Jr, Li WW. Alzheimer's disease and angiogenesis. Lancet. 2003 Feb 15;361(9357):605-8. Review.</citation>
    <PMID>12598159</PMID>
  </reference>
  <reference>
    <citation>Hanon O, Haulon S, Lenoir H, Seux ML, Rigaud AS, Safar M, Girerd X, Forette F. Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss. Stroke. 2005 Oct;36(10):2193-7. Epub 2005 Sep 8.</citation>
    <PMID>16151027</PMID>
  </reference>
  <reference>
    <citation>Redheuil A, Yu WC, Wu CO, Mousseaux E, de Cesare A, Yan R, Kachenoura N, Bluemke D, Lima JA. Reduced ascending aortic strain and distensibility: earliest manifestations of vascular aging in humans. Hypertension. 2010 Feb;55(2):319-26. doi: 10.1161/HYPERTENSIONAHA.109.141275. Epub 2010 Jan 11.</citation>
    <PMID>20065154</PMID>
  </reference>
  <reference>
    <citation>Redheuil A, Yu WC, Mousseaux E, Harouni AA, Kachenoura N, Wu CO, Bluemke D, Lima JA. Age-related changes in aortic arch geometry: relationship with proximal aortic function and left ventricular mass and remodeling. J Am Coll Cardiol. 2011 Sep 13;58(12):1262-70. doi: 10.1016/j.jacc.2011.06.012.</citation>
    <PMID>21903061</PMID>
  </reference>
  <reference>
    <citation>Rosenbaum D, Koch E, Girerd X, Rossant F, Pâques M. [Imaging of retinal arteries with adaptative optics, feasibility and reproducibility]. Ann Cardiol Angeiol (Paris). 2013 Jun;62(3):184-8. doi: 10.1016/j.ancard.2013.04.017. Epub 2013 May 29. French.</citation>
    <PMID>23773704</PMID>
  </reference>
  <reference>
    <citation>Herment A, Kachenoura N, Lefort M, Bensalah M, Dogui A, Frouin F, Mousseaux E, De Cesare A. Automated segmentation of the aorta from phase contrast MR images: validation against expert tracing in healthy volunteers and in patients with a dilated aorta. J Magn Reson Imaging. 2010 Apr;31(4):881-8. doi: 10.1002/jmri.22124.</citation>
    <PMID>20373432</PMID>
  </reference>
  <reference>
    <citation>Bollache E, Kachenoura N, Redheuil A, Frouin F, Mousseaux E, Recho P, Lucor D. Descending aorta subject-specific one-dimensional model validated against in vivo data. J Biomech. 2014 Jan 22;47(2):424-31. doi: 10.1016/j.jbiomech.2013.11.009. Epub 2013 Nov 15.</citation>
    <PMID>24290136</PMID>
  </reference>
  <reference>
    <citation>Dogui A, Kachenoura N, Frouin F, Lefort M, De Cesare A, Mousseaux E, Herment A. Consistency of aortic distensibility and pulse wave velocity estimates with respect to the Bramwell-Hill theoretical model: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2011 Jan 27;13:11. doi: 10.1186/1532-429X-13-11.</citation>
    <PMID>21272312</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2015</study_first_submitted>
  <study_first_submitted_qc>March 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2016</study_first_posted>
  <last_update_submitted>March 2, 2016</last_update_submitted>
  <last_update_submitted_qc>March 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

